Hepatitis B and C Co-infection in HIV/AIDS Population in the State of Michigan

Overview

Journal Epidemiol Infect

Publisher Cambridge University Press

Specialties Infectious Diseases
Public Health

Date 2013 Mar 14

PMID 23481310

Citations 4

Authors

Z A Butt

M J Wilkins

E Hamilton

D Todem

J C Gardiner

M Saeed

Affiliations

Soon will be listed here.

Abstract

A retrospective cohort study was conducted from 1 January 2006 to 31 December 2009 in Michigan to estimate the prevalence of HIV and hepatitis co-infection and identify associated factors. The prevalence of co-infection was 4.1% [95% confidence interval (CI) 3.8-4.5]. Multivariable logistic regression analysis revealed a significant association between co-infection and being male and: of Black race [odds ratio (OR) 2.0, 95% CI 1.2-3.6] and of Other race (OR 3.5, 95% CI 1.7-7.0) compared to Hispanic race. A significant association was found between co-infection and risk categories of blood products (OR 11.1, 95% CI 6.2-20.2), injecting drug user (IDU) (OR 3.6, 95% CI 2.7-4.8) and men who have sex with men/IDU (OR 3.4, 95% CI 2.4-4.9) in addition to two interactions; one between sex and current HIV status and the other between current HIV status and age at HIV diagnosis. Our results document the changing epidemiology of HIV-hepatitis co-infection which can guide preventive measures and interventions to reduce the prevalence of hepatitis co-infection.

Citing Articles

Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis.

Platt L, French C, McGowan C, Sabin K, Gower E, Trickey A J Viral Hepat. 2019; 27(3):294-315.

PMID: 31603999 PMC: 7383613. DOI: 10.1111/jvh.13217.

HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities.

Bosh K, Coyle J, Hansen V, Kim E, Speers S, Comer M Epidemiol Infect. 2018; 146(7):920-930.

PMID: 29636119 PMC: 5957777. DOI: 10.1017/S0950268818000766.

HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.

Prussing C, Chan C, Pinchoff J, Kersanske L, Bornschlegel K, Balter S Epidemiol Infect. 2014; 143(7):1408-16.

PMID: 25170631 PMC: 9507198. DOI: 10.1017/S0950268814002209.

Survival of HIV-positive individuals with hepatitis B and C infection in Michigan.

Butt Z, Wilkins M, Hamilton E, Todem D, Gardiner J, Saeed M Epidemiol Infect. 2013; 142(10):2131-9.

PMID: 24286128 PMC: 9151294. DOI: 10.1017/S0950268813003038.

References

Lincoln D, Petoumenos K, Dore G . HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med. 2003; 4(3):241-9. DOI: 10.1046/j.1468-1293.2003.00152.x. View

Dwyre D, Fernando L, Holland P . Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang. 2010; 100(1):92-8. DOI: 10.1111/j.1423-0410.2010.01426.x. View

Kellerman S, Hanson D, McNaghten A, Fleming P . Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis. 2003; 188(4):571-7. DOI: 10.1086/377135. View

Chun H, Fieberg A, Hullsiek K, Lifson A, Crum-Cianflone N, Weintrob A . Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years. Clin Infect Dis. 2010; 50(3):426-36. PMC: 2805765. DOI: 10.1086/649885. View

Dorrucci M, Valdarchi C, Suligoi B, Zaccarelli M, Sinicco A, Giuliani M . The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy. AIDS. 2004; 18(17):2313-8. DOI: 10.1097/00002030-200411190-00012. View

Victoria M, da Silva Victoria F, Torres K, Kashima S, Covas D, Malheiro A . Epidemiology of HIV/HCV coinfection in patients cared for at the Tropical Medicine Foundation of Amazonas. Braz J Infect Dis. 2010; 14(2):135-40. DOI: 10.1590/s1413-86702010000200004. View

Romeo R, Rumi M, Donato M, Cargnel M, Vigano P, Mondelli M . Hepatitis C is more severe in drug users with human immunodeficiency virus infection. J Viral Hepat. 2000; 7(4):297-301. DOI: 10.1046/j.1365-2893.2000.00230.x. View

Filho A, do Nascimento C, Tannouri T, Troiani C, Ascencio E, Bonfim R . Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil. Mem Inst Oswaldo Cruz. 2009; 104(7):960-3. DOI: 10.1590/s0074-02762009000700003. View

Anderson K, Guest J, Rimland D . Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clin Infect Dis. 2004; 39(10):1507-13. DOI: 10.1086/425360. View

10.

Montgomery S, Hyde J, De Rosa C, Rohrbach L, Ennett S, Harvey S . Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002; 28(3):453-75. DOI: 10.1081/ada-120006736. View

11.

Puoti M, Airoldi M, Bruno R, Zanini B, Spinetti A, Pezzoli C . Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev. 2002; 4(1):27-35. View

12.

. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41(RR-17):1-19. View

13.

Sherman K, Rouster S, Chung R, Rajicic N . Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002; 34(6):831-7. DOI: 10.1086/339042. View

14.

Barth R, Huijgen Q, Taljaard J, Hoepelman A . Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010; 14(12):e1024-31. DOI: 10.1016/j.ijid.2010.06.013. View

15.

Bodsworth N, Cooper D, Donovan B . The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis. 1991; 163(5):1138-40. DOI: 10.1093/infdis/163.5.1138. View

16.

Kuniholm M, Mark J, Aladashvili M, Shubladze N, Khechinashvili G, Tsertsvadze T . Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients. Int J Infect Dis. 2007; 12(1):51-6. PMC: 2649965. DOI: 10.1016/j.ijid.2007.04.015. View

17.

Goodenow C, Netherland J, Szalacha L . AIDS-related risk among adolescent males who have sex with males, females, or both: evidence from a statewide survey. Am J Public Health. 2002; 92(2):203-10. PMC: 1447043. DOI: 10.2105/ajph.92.2.203. View

18.

Tedaldi E, Hullsiek K, Malvestutto C, Arduino R, Fisher E, Gaglio P . Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis. 2003; 36(10):1313-7. DOI: 10.1086/374841. View

19.

Reuter S, Oette M, Wilhelm F, Beggel B, Kaiser R, Balduin M . Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients. Med Microbiol Immunol. 2010; 200(1):39-49. DOI: 10.1007/s00430-010-0172-z. View